tiprankstipranks
Trending News
More News >
Biosyent Inc (TSE:RX)
:RX
Canadian Market

Biosyent (RX) Ratios

Compare
45 Followers

Biosyent Ratios

TSE:RX's free cash flow for Q3 2024 was C$0.78. For the 2024 fiscal year, TSE:RX's free cash flow was decreased by C$ and operating cash flow was C$0.31. See a summary of the company’s cash flow.
Ratios
TTM
Dec 23Dec 22Dec 21Dec 20
Liquidity Ratios
Current Ratio
6.48 6.49 8.24 5.79 7.99
Quick Ratio
5.42 5.70 7.70 5.39 7.36
Cash Ratio
1.44 1.38 4.36 3.95 4.00
Solvency Ratio
1.02 0.83 1.20 0.64 0.90
Operating Cash Flow Ratio
0.91 0.87 1.13 1.34 1.42
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
C$ 29.10MC$ 30.02MC$ 28.47MC$ 23.00MC$ 21.67M
Leverage Ratios
Debt-to-Assets Ratio
0.03 0.03 0.04 0.05 0.06
Debt-to-Equity Ratio
0.04 0.04 0.05 0.06 0.07
Debt-to-Capital Ratio
0.03 0.04 0.05 0.06 0.07
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.19 1.21 1.18 1.25 1.20
Debt Service Coverage Ratio
102.09 77.60 80.05 47.33 144.61
Interest Coverage Ratio
109.21 90.51 96.00 54.12 166.01
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
0.11 0.12 0.13 0.14 0.14
Net Debt to EBITDA
-0.75 -0.81 -1.85 -3.18 -1.87
Profitability Margins
Gross Profit Margin
81.03%81.85%79.10%78.02%77.70%
EBIT Margin
27.23%25.00%28.59%22.52%27.55%
EBITDA Margin
28.67%28.50%31.17%26.15%28.91%
Operating Profit Margin
23.65%25.00%28.59%22.52%25.15%
Pretax Profit Margin
27.01%26.61%29.28%23.45%27.40%
Net Profit Margin
20.45%19.55%21.95%16.99%20.39%
Continuous Operations Profit Margin
20.45%19.55%21.95%16.99%20.39%
Net Income Per EBT
75.70%73.46%74.97%72.47%74.43%
EBT Per EBIT
114.22%106.43%102.39%104.11%108.95%
Return on Assets (ROA)
15.56%13.48%16.90%11.31%14.11%
Return on Equity (ROE)
18.59%16.36%19.91%14.16%16.94%
Return on Capital Employed (ROCE)
20.76%20.08%24.77%17.69%19.52%
Return on Invested Capital (ROIC)
15.63%14.68%18.48%12.75%14.45%
Return on Tangible Assets
16.00%13.89%17.31%11.66%14.59%
Earnings Yield
6.04%6.34%5.99%3.69%5.14%
Efficiency Ratios
Receivables Turnover
8.91 8.78 11.47 12.30 10.28
Payables Turnover
1.18 1.00 1.68 1.32 1.64
Inventory Turnover
1.02 1.12 2.71 2.37 2.23
Fixed Asset Turnover
21.94 16.69 14.82 10.33 8.63
Asset Turnover
0.76 0.69 0.77 0.67 0.69
Working Capital Turnover Ratio
1.02 0.91 1.05 0.93 0.88
Cash Conversion Cycle
90.73 3.57 -51.12 -93.03 -23.91
Days of Sales Outstanding
40.98 41.57 31.81 29.66 35.50
Days of Inventory Outstanding
359.04 326.68 134.54 154.20 163.41
Days of Payables Outstanding
309.29 364.68 217.47 276.89 222.82
Operating Cycle
400.02 368.26 166.35 183.86 198.91
Cash Flow Ratios
Operating Cash Flow Per Share
0.42 0.40 0.37 0.53 0.34
Free Cash Flow Per Share
0.41 0.36 0.36 0.52 0.29
CapEx Per Share
0.01 0.04 <0.01 0.01 0.05
Free Cash Flow to Operating Cash Flow
0.97 0.90 0.98 0.97 0.85
Dividend Paid and CapEx Coverage Ratio
2.42 4.93 50.17 39.56 6.50
Capital Expenditure Coverage Ratio
29.01 9.53 50.17 39.56 6.50
Operating Cash Flow Coverage Ratio
4.14 3.55 3.00 4.03 2.57
Operating Cash Flow to Sales Ratio
0.16 0.18 0.16 0.31 0.22
Free Cash Flow Yield
4.56%5.14%4.37%6.54%4.75%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
16.56 15.78 16.69 27.09 19.47
Price-to-Sales (P/S) Ratio
3.39 3.08 3.66 4.60 3.97
Price-to-Book (P/B) Ratio
3.08 2.58 3.32 3.84 3.30
Price-to-Free Cash Flow (P/FCF) Ratio
21.91 19.44 22.88 15.30 21.07
Price-to-Operating Cash Flow Ratio
21.16 17.40 22.42 14.91 17.83
Price-to-Earnings Growth (PEG) Ratio
0.73 -1.31 0.23 -4.20 -0.95
Price-to-Fair Value
3.08 2.58 3.32 3.84 3.30
Enterprise Value Multiple
11.06 10.01 9.90 14.42 11.86
EV to EBITDA
11.06 10.01 9.90 14.42 11.86
EV to Sales
3.17 2.85 3.09 3.77 3.43
EV to Free Cash Flow
20.53 17.98 19.28 12.53 18.20
EV to Operating Cash Flow
19.82 16.10 18.90 12.22 15.40
Tangible Book Value Per Share
2.81 2.61 2.42 1.98 1.78
Shareholders’ Equity Per Share
2.91 2.71 2.49 2.06 1.85
Tax and Other Ratios
Effective Tax Rate
0.24 0.27 0.25 0.28 0.26
Revenue Per Share
2.64 2.27 2.26 1.72 1.54
Net Income Per Share
0.54 0.44 0.50 0.29 0.31
Tax Burden
0.76 0.73 0.75 0.72 0.74
Interest Burden
0.99 1.06 1.02 1.04 0.99
Research & Development to Revenue
<0.01 <0.01 <0.01 0.01 <0.01
SG&A to Revenue
0.31 0.32 0.16 0.18 0.52
Stock-Based Compensation to Revenue
0.02 0.02 0.01 0.01 0.01
Income Quality
0.78 0.91 0.74 1.82 1.09
Currency in CAD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis